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Abstract. -Synuclein aggregation is one of the major etiological factors implicated in Parkinson’s disease (PD). The prevention
of aggregation of -synuclein is a potential therapeutic intervention for preventing PD. The discovery of natural products as
alternative drugs to treat PD and related disorders is a current trend. The aqueous extract of Centella asiatica (CA) is traditionally
used as a brain tonic and CA is known to improve cognition and memory. There are limited data on the role of CA in modulating
amyloid- (A) levels in the brain and in A aggregation. Our study focuses on CA as a modulator of the-synuclein aggregation
pattern in vitro. Our investigation is focused on: (i) whether the CA leaf aqueous extract prevents the formation of aggregates from
monomers (Phase I: -synuclein + extract co-incubation); (ii) whether the CA aqueous extract prevents the formation of fibrils
from oligomers (Phase II: extract added after oligomers formation); and (iii) whether the CA aqueous extract disintegrates the
pre-formed fibrils (Phase III: extract added to mature fibrils and incubated for 9 days). The aggregation kinetics are studied using
a thioflavin-T assay, circular dichroism, and transmission electron microscopy. The results showed that the CA aqueous extract
completely inhibited the -synuclein aggregation from monomers. Further, CA extract significantly inhibited the formation of
oligomer aggregates and favored the disintegration of the preformed fibrils. The study provides an insight in finding new natural
product for future PD therapeutics.
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INTRODUCTION25
Parkinson’s disease (PD) arises from the loss of26
dopaminergic neurons in the substantia nigra region27
of the brain [1]. The etiology of PD is complex and28
the mechanisms of the development of the disease are29
still not clear [2, 3]. Among the different mechanisms30
proposed, the aggregation pathway of -synuclein is31
considered as the classical pathway leading to the
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disease [4–6]. In this pathway, the central event is 32
that monomers of-synuclein form soluble oligomers, 33
which finally lead to the formation of mature insolu- 34
ble fibrils in the brain through a multistep process [7, 35
8]. Inhibition of -synuclein aggregation has become 36
a major therapeutic target [9]. Various compounds, 37
both synthetic and natural, are being used against the 38
neurodegenerative diseases, targeting protein aggrega- 39
tion as a central pathway [10]. Currently, screening 40
of potential compounds for preventing -synuclein 41
aggregation is a drug target. Natural compounds are 42
a good source of potential compounds to modulate 43
neurodegenerative diseases [11–16]. 44
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Centella asiatica (CA), a herb grown in India and45
other Asian countries, is considered to be a poten-46
tial candidate drug against neurodegenerative diseases.47
The plant is used widely in Indian traditional medicine48
as a brain tonic [17, 18]. There are limited studies49
showing that CA has the ability to increase memory and50
cognition [19, 20]. Gadahad et al. [21] have shown that51
CA has neuronal dendritic growth stimulating proper-52
ties. Xu et al. [22] showed that a CA extract enhanced53
the phosphorylation of cyclic AMP response element54
binding protein and thus played a role as a memory55
enhancer. An aqueous extract of CA is found to pre-56
vent streptozotocin-induced cognitive deficits in rats57
[23]. The CA extract decreased the amyloid load in58
the brains of animal models with Alzheimer’s disease59
[24]. All of the above studies and traditional knowledge60
indicate that compounds in the leaf extract of CA may61
have neuroprotective potential. However, there are no62
studies to indicate whether CA could be of potential63
use against PD.64
PD is characterized by the presence of Lewy bodies65
(-synuclein aggregates) in the substantia nigra. -66
Synuclein aggregates into fibrils through multiple steps67
involving soluble oligomers and insoluble protofibrils68
and fibrils [7, 8]. We analyzed the potential role of a69
CA leaf aqueous extract in inhibiting the -synuclein70
aggregation under in vitro conditions. We used an in71
vitro aggregation model as a quick battery test for72
the screening of compounds for their anti-aggregating73
potentials. We analyzed the anti-aggregating proper-74
ties of CA leaf extract in the three steps of -synuclein75
aggregation dynamics: (i) Phase I: monomer to aggre-76
gates, (ii) Phase II: oligomer to aggregates, and (iii)77
Phase III: disintegration of preformed fib ils of -78
synuclein aggregation.79
MATERIALS AND METHODS80
-Synuclein was purchased from rpeptide, USA.81
Tris buffer, glycine, sodium hydroxide, hydrochloric82
acid, and uranyl acetate were procured from BDH83
Laboratory chemicals Division. Thioflavin-T was pur-84
chased from ICN Biomedicals Pvt. Ltd, USA. Copper85
grids (200 mesh size) were purchased from Sigma86
Chemicals, USA.87
Preparation of aqueous extract from the leaves of88
Centella asiatica89
CA was grown under controlled conditions. The90
plant was cleaned with triple-distilled water and the91
leaves were separated and freeze-dried. The leaf aque-92
ous extract was prepared by boiling the leaves in 93
triple-distilled water and lyophilized and stored at 94
−80◦C. 95
Experimental design 96
We tested for anti-aggregating properties of the CA 97
leaf aqueous extract in three phases of the aggregation 98
pathway. First, we sought to understand the prevention 99
of -synuclein aggregation from monomers to aggre- 100
gates (Phase I). -Synuclein (50M) was dissolved 101
in 20 mM Tris-HCl pH (8.4), and 100g of freshly 102
dissolved CA leaf aqueous extract was added and con- 103
tinuously stirred using magnetic beads. We studied 104
the aggregation kinetics to follow monomer-oligomer- 105
aggregate phases as a function of time (0–96 h). 106
Aliquots were taken at regular intervals of 8 h start- 107
ing for 0 h to 96 h for the thioflavin-T and transmission 108
electron microscopy (TEM) analyses. A control exper- 109
iment of -synuclein aggregation alone, in the absence 110
of leaf extract, was carried out as above. -Synuclein 111
was dissolved in triple-distilled water and centrifuged 112
at 10,000 rpm at 4◦C before incubating for the aggre- 113
gation. The supernatant was taken for the monomers of 114
-synuclein and any aggregates remained in the precip- 115
itate. Second, we sought to understand the prevention 116
of -synuclein aggregation from oligomer to aggre- 117
gates (Phase II). -Synuclein oligomers were prepared 118
according to Danzer et al. [25] with little modification. 119
-Synuclein (50M) was dissolved in Tris buffer and 120
incubated at 37◦C with constant stirring for 24 h (at 121
which point oligomers appeared). The incubation mix- 122
ture was then centrifuged at 10,000 rpm to remove any 123
protofibrils formed, and the supernatant, which con- 124
tained the oligomers, was removed. We added 100g 125
of CA leaf aqueous extract to the oligomers and incu- 126
bated the mixture for aggregation at 37◦C with constant 127
stirring. Aliquots were taken at time intervals of 0 h, 128
24 h, 48 h, and 96 h for thioflavin-T and TEM analyses. 129
Finally, we conducted a third experiment to under- 130
stand the efficiency of the CA extract to disintegrate 131
the pre-formed fibrils (Phase III). Here, freshly pre- 132
pared -synuclein was allowed to form mature fibrils 133
for 96 h and then 100g extract CA was added to the 134
mature fibrils. We then followed the disintegration of 135
fibrils for 10 days. 136
Thioflavin-T assay 137
The thioflavin-T assay was conducted to under- 138
stand the protein aggregation kinetics. Thioflavin-T 139
specifically binds to aggregates. 25l of (1 mM) 140
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thioflavin-T was added to 1000l of total reaction141
volume. Thioflavin-T fluorescence was measured at142
excitation and emission wavelengths of 446 nm and143
482 nm, respectively, using a F4500 Hitachi fluo-144
rescence spectrometer. The background thioflavin-T145
fluorescence intensity was subtracted from the experi-146
mental values.147
Transmission electron microscopy study148
TEM was used to detect the presence or absence of149
aggregates. 10L of incubated sample was placed on a150
carbon-coated copper grid (200 mesh size) and allowed151
to rest for 1 min. Excess sample was wicked off with152
lens paper and then negatively stained by transferring153
the grid face down to a droplet of (2% (w/v) uranyl154
acetate for 1 min before wicking off the solution. Then155
the grids were air dried for 1 h. Four individual experi-156
ments were carried out for each sample. The grids were157
completely dried to avoid moisture and then scanned158
under JOEL 1010 TEM.159
Circular dichroism (CD) studies of the160
aggregation of α-synuclein161
A CD study was conducted to understand the162
binding and to observe any secondary conformation163
changes of -synuclein in the three phases of the164
aggregation process. 20L of incubated sample was165
taken and spectra were recorded on a JASCO J700166
Spectropolarimeter at 25◦C, with 2 mm cell length in167
the wavelength range between 200–320 nm in Tris-Cl168
buffer (5 mM, pH 7.4). Each spectrum was calculated169
as the average of four scans.170
SDS-polyacrylamide gel electrophoresis171
To further understand whether molecules in the CA172
extract bind to -synuclein, we conducted SDS-PAGE173
for the samples [26]. 15l of pre-incubated samples174
were mixed with 15l of SDS-PAGE sample buffer175
and loaded onto a 12% SDS- polyacrylamide gel with-176
out boiling. Low molecular weight markers were used177
as molecular weight standards. The samples were elec-178
trophoresed at 100 V at room temperature for 4 h. The179
gels were stained for protein with 0.1% Coomassie180
Brilliant Blue.181
Estimation of polyphenols in the CA water extract182
The total phenol content of the CA water extract183
was estimated using Folin-Ciocalteu (F-C) reagent184
[27]. The polyphenols in the aqueous extract of 185
CA were separated on a reverse-phase C18 column 186
(4.6 × 2.50 mm) using HPLC system (agilent-Model 187
1200 series) and a diode array detector (operating at 188
280 nm and 320 nm). The solvent system consisted of 189
a mixture of water: methanol: acetic acid (83 : 15 : 2), 190
which was used as mobile phase (isocratic) at a flow 191
rate of 1 ml/min [28]. The known quantities refer- 192
ence phenolic acid standards such as caffeic acid, 193
p-coumaric acid, cinnamic acid, ferulic acid, gallic 194
acid, gentisic acid, protocatechuic acid, syringic acid, 195
and vanillic acid were studied for identification and 196
quantification of phenolic acids present in the extract. 197
We also estimated the levels of asiatic acid by HPLC 198
and selenium by ICP-AES. 199
Statistical analysis 200
All data were analyzed using SAS/STAT® Software, 201
USA. 202
RESULTS 203
Phase I 204
Thioflavin-T assay 205
Thioflavin-T fluorescence of aggregation kinetics 206
followed a sigmoidal curve. Figure 1A shows three 207
phases of aggregation kinetics of-synuclein as a func- 208
tion of time (0–96 h). The thioflavin-T data indicated a 209
lag period for the first 24 h, where thioflavin-T fluores- 210
cence intensity was static, indicating the presence of 211
monomers only. After 24 h, there was an intermediate 212
phase during which oligomers and other intermedi- 213
ate forms might have formed until 90 h. After 90 h we 214
observed a saturated phase, where fully matured fib- 215
rils were formed, and here thioflavin-T fluorescence 216
reached a plateau. In the presence of the CA aqueous 217
extract, the sigmoidal pattern of -synuclein aggre- 218
gation kinetics was prevented. Here there was only 219
a lag phase with possibly the presence of monomers 220
only. Figure 1B shows the thioflavin-T fluorescence 221
at 0, 24, 48, and 96 h time intervals. For -synuclein 222
alone, thioflavin-T fluorescence increases as a func- 223
tion of time, indicating the formation of aggregates 224
from oligomers. But, in the presence of the CA aque- 225
ous extract, thioflavin-T fluorescence did not increase, 226
indicating that the extract inhibited the aggregation of 227
oligomers. We also conducted electrophoresis studies 228
to understand the binding of molecules in the extract 229
to monomers and aggregates. We did not find any shift 230
in the mobility of bands or any other changes between 231
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Fig. 1. Studies on the role of CA in modulating synuclein aggregation. A) Phase I (monomers to aggregates). B) Phase I: Bar diagram showing
the Thioflavin-T fluorescence of -synuclein in presence or absence of CA leaf extract. C) Phase I: transmission electron microscopic study.
the treatment and the control (data not shown). Hence,232
we conducted CD studies to understand the binding of233
the molecules in the extract to synuclein and to test for234
changes in the secondary conformations of synuclein235
if the molecules are binding.236
TEM study237
TEM pictures were analyzed for the aggregation238
kinetics at time intervals of 0, 24, 48, and 96 h, respec-239
tively (Fig. 1C). The TEM data clearly showed that240
there were no aggregates at 0 and 24 h in the control241
experiment. The aggregates started growing from 48242
and 96 h onwards (Fig. 1C). But, in the presence of243
the CA leaf extract, there was no presence of aggre-244
gates at time intervals of 24, 48, and 96 h, indicating245
that the CA leaf extract completely prevented the for-246
mation of aggregates (Fig. 1C). Both Thioflavin-T and247
TEM data clearly supported that the CA extract totally248
prevented the formation of aggregates and the data are249
statistically significant (p < 0.001).250
CD studies251
The binding and secondary conformation of -252
synuclein at time intervals of 0, 24, 48, and 96 h in the253
presence and absence of CA water extract are presented 254
in Fig. 2A and B. Figure 2A indicates that -synuclein 255
exists in random coil conformation. The aggregated 256
-synuclein is in -sheet conformation as evidenced 257
by the decrease in the 200 nm negative peak and the 258
increase in the 230 nm negative peak (Fig. 2B). In the 259
presence of the CA water extract, -synuclein stayed 260
in the random coil conformation, indicating stability 261
of monomers (Fig. 2A, B). 262
Phase II 263
Thioflavin-T assay 264
Thioflavin T fluorescence during the second phase of 265
the aggregation process from oligomers is represented 266
in Fig. 3A. In the control experiment, Thioflavin-T 267
fluorescence increased as a function of time, indi- 268
cating the formation of aggregates from oligomers. 269
When the CA leaf extract was introduced at the time 270
of oligomer formation, the intensity of Thioflavin-T 271
decreased. This indicated that the CA leaf extract could 272
able to prevent the formation of aggregates and the all 273
the above data are statistically significant (p < 0.001).
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Fig. 2. Studies on the role of CA in modulating synuclein conformation. Circular dichroism (CD) spectra of -synuclein aggregation. A) CD
spectra of -synuclein aggregation (Phase I, monomers to aggregates) at time intervals 0 h (solid line) and 24 h (dashed line), and in the presence
of the CA water extract at 0 h (dotted line) and 24 h (dashed and double dotted line). B) CD spectra of -synuclein aggregation (Phase I:
monomers to aggregates) at time intervals 48 h (solid line) and 96 h (dashed line), and in the presence of CA water extract at 0 h (dotted line)
and 24 h (dashed and double dotted line). C) CD spectra of -synuclein aggregation (Phase II: oligomers to aggregates) at time intervals 24 h
(solid line), 48 h (dotted line), and 96 h (dashed line), and in the presence of the CA water extract at time intervals 24 h (hollow dashed line),
48 h (dashed and double dotted line), and 96 h (dashed and dotted line). D) CD spectra of -synuclein aggregation (Phase III: disintegration of
fibrils): 96 h aggregates (solid line) and 96 h aggregates treated with CA plant extract (dotted line).
TEM study274
Figure 3B shows the results of TEM of Phase II.275
The fibrils formation increased with time from 24 h to276
96 h in the treatment with -synuclein alone (oligomer277
to fibrils). The CA extract appeared to effectively pre-278
vent the formation of fibrils as very few fibrils were279
observed and the data is significant at p < 0.001.280
CD studies281
-Synuclein went into the -sheet conformation282
in the aggregation kinetics from 24 to 96 h. In the283
presence of the CA water extract, -synuclein was284
in a mixed conformation (random coil and -sheet)285
(Fig. 2C).286
Phase III287
Thioflavin-T assay288
Figure 4A shows the results of Thioflavin-T fluo-289
rescence assay of Phase III. The fluorescence intensity290
after 96 h of the aggregated sample treated with the 291
CA extract for 10 days showed an approximately 292
50% decrease relative to the 96 h aggregated control 293
sample. This indicates that CA may disintegrate pre- 294
formed fibrils up to 50% and the data is significant at 295
p < 0.05. 296
TEM study 297
Figure 4B shows the results of TEM of Phase III. The 298
-synuclein (96 h incubated) aggregates showed a high 299
density of mature fibrils. The incubation of these fibrils 300
with the CA extract for 10 days resulted in a reduced 301
density of fibrils, indicating that the CA extract may 302
be able to disintegrate the fibrils by up to 70%, and the 303
data is significant at p < 0.001. 304
CD studies 305
-Synuclein went into a -sheet conformation 306
at 96 h. In the presence of the CA water extract, 307
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Fig. 3. Studies on the role of CA in modulating synuclein aggregation. A) Phase II (oligomers to aggregates): Bar diagram showing the
Thioflavin-T fluorescence of -synuclein as a function of time. B) Phase II (transmission electron microscopy study): Aliquots were analyzed
for the presence or absence of aggregates using electron microscopy.
-synuclein was predominantly in a random coil (ran-308
dom coil and partly -sheet form) (Fig. 2D).309
Polyphenol content in CA extract310
The total phenolic content of the CA water extract311
was 1.83 mg/ml. The extract was found to have312
molecules of caffeic acid followed by p-coumaric acid, 313
gentisic acid, protocatechuic acid, chlorogenic acid, 314
gallic acid, asiatic acid, ferulic acid, and selenium 315
(Table 1). We still believe that there may be additional 316
unidentified small molecules in the extract, which is 317
under exploration currently. 318
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Fig. 4. Studies on the role of CA in modulating synuclein aggregation. A) Phase III (disintegration of preformed fibrils): Bar diagram showing
the Thioflavin-T fluorescence of-synuclein. B) Phase III (transmission electron microscopy study): The aliquots were analyzed for the presence
or absence of aggregates using electron microscopy.
Table 1
Phenolic content in aqueous extract of Centella asiatica (CA). The
values are expressed as mean and standard deviation
Sample CA (g/g dry extract)
Gallic acid 65.56 ± 2.33
Protocatechuic acid 135.65 ± 7.21
Gentisic acid 172.78 ± 8.51
Chlorogenic acid 109.56 ± 6.87
Caffeic acid 512.57 ± 9.34
P-Coumaric acid 410.21 ± 9.13
Ferulic acid 21.76 ± 1.93
Asiatic acid 1.4 ± 0.21
Selenium 2.8 ± 0.32
DISCUSSION319
PD has complex pathology with multiple etiolo-320
gies [1]. The aggregation of -synuclein leading to321
the degeneration of dopaminergic neurons in substan-322
tia nigra is the central pathway involved in PD [1].323
Currently, the drugs used for the treatment of PD are324
supplementing DOPA (a neurotransmitter secreted by325
the dopaminergic neurons) to stimulate the neurons of326
substantia nigra, and there are very few drugs targeting327
the aggregation pathway [29, 30]. Progressive neu-328
rodegeneration is seen even in patients taking drugs. 329
The drugs used for PD relieve the symptoms but are not 330
able to prevent neurodegeneration. After 5–10 years of 331
treatment, patients become resistant to drugs because 332
the number of neurons stimulated by the decreases over 333
time. Discovering new drugs that can target the pro- 334
tein aggregation pathway will be a good alternative 335
therapeutic approach. 336
-Synuclein is hypothesized to have multiple 337
functions in the cell. -Synuclein aggregation is 338
responsible for neuronal dysfunction and PD [4–6]. 339
However, -synuclein aggregation dynamics are 340
complex and multifactorial. Soluble -synuclein 341
monomers exist predominantly in the random coil 342
secondary conformation. During the onset of aggre- 343
gation, natively random coil folded monomers turn 344
into misfolded oligomers. The drug molecules so 345
far reported are targeted toward the prevention of 346
aggregates without much attention to aggregation con- 347
formation dynamics. There are few mechanistic studies 348
focused on understanding the neuroprotective role of 349
CA and these studies focused primarily on cognition, 350
decrease in amyloid load, etc. [19, 20, 22–24, 31, 32]. 351
There are also reports indicating that the CA aqueous 352
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extract cannot inhibit the A aggregation from both353
monomer and oligomers, nor could it disintegrate the354
preformed fibrils under in vitro conditions. However,355
the reason for this behavior is not explored in the paper356
[33]. We hypothesize that A has a single methion-357
ine at residue 35, while synuclein has four methionine358
residues in-synuclein. As we elaborate below, natural359
compounds preferentially bind to methionine and can360
help modulate the assembly of synuclein. We postulate361
that the presence of a number of methionine residues362
may be responsible for the differential action of CA on363
A and synuclein.364
The present study was focused on understanding365
the modulation of aggregation and conformation pat-366
terns of the synuclein protein in vitro. We analyzed367
the ability of CA extract to prevent -synuclein aggre-368
gation in three different phases. Our most significant369
result is that the CA aqueous extract prevented the370
aggregation of monomers to oligomers by retaining the371
random coil structure of synuclein. This indicates that372
the CA aqueous extract stabilized the monomer of -373
synuclein, thereby preventing the aggregation. The CA374
aqueous extract also effectively inhibited the oligomer375
going into the aggregation step, and caused the disin-376
tegration of preformed fibrils to greater extent (70%).377
These results are promising in furthering our attempts378
to discover new drugs to treat PD.379
There are few studies on the neuroprotective role380
of polyphenols in PD models. The conjugate of381
dopamine, 5-S-cysteinyl-dopamine, causes neurotox-382
icity, possibly leading to PD pathology. Vauzour et383
al. [34] reported that the hydroxycinnamates caffeic384
acid and p-coumaric acid, and the hydroxyphenethyl385
alcohol, tyrosol, are able to protect neurons against386
neurotoxicity induced by 5-S-cysteinyl-dopamine in387
vitro. Jimenez-Del-Rio et al. [35] reported that pure388
polyphenols such as gallic acid, ferulic acid, caffeic389
acid, coumaric acid, propyl gallate, epicatechin, epigal-390
locatechin, and epigallocatechin gallate could protect391
the impaired movement activity induced by paraquat392
in Drosophila. In addition, the caffeic acid phenethyl393
ester has been found to prevent 6-hydroxydopamine-394
induced neurotoxicity in intrastriatal rodent models395
[36]. Ono and Yamada [37] reported that compounds396
like nordihydroguaiaretic acid, curcumin, rosmarinic397
acid, ferulic acid, tannic acid, myricetin, kaempferol398
(+)-catechin and (−)-epicatechin, rifampicin, and399
tetracycline not only prevent the formation of -400
synuclein fibrils but also destabilize preformed fibrils.401
Recently, Caruana et al. [38] reported 14 natu-402
ral polyphenols that are able to inhibit -synuclein403
oligomer formation and also destabilize pre-formed404
-synuclein oligomers. Our leaf water extract has com- 405
pounds like caffeic acid, p-coumaric acid, gentisic acid, 406
protocatechuic acid, chlorogenic acid, gallic acid, and 407
ferulic acid, asiatic acid, and selenium, and we believe 408
that these compounds act synergistically to prevent 409
synuclein assembly in vitro, but further investigations 410
are in progress. 411
However, the mechanisms through which natural 412
compounds modulate synuclein assemblies remain 413
unclear. Peptide mapping and mass spectrometric stud- 414
ies indicate that synuclein is oxidized at all four 415
methionine residues when synuclein is incubated with 416
polyphenol inhibitors namely exifone, gossypetin, 417
and dopamine. These studies have shown that the 418
inhibitors bind to N-terminal region, which plays 419
a key role in synuclein dimerization and aggrega- 420
tion, while the C-terminal region plays a key role 421
in retaining the random-coil character [39]. Other 422
studies have shown that polyphenols have aromatic ele- 423
ments and vicinal hydroxyl groups on a single phenyl 424
ring. These groups play a key role for polyphenol 425
binding to monomer/oligomer and also for destabi- 426
lizing self-assembly of synuclein [37]. It has also 427
been proposed that polyphenols bind to synuclein by 428
strong non-specific hydrophobic associations and also 429
non-covalent pi-pi stacking interactions through aro- 430
matic residues present in synuclein sequence [40]. 431
Still more investigations are needed to understand the 432
mechanisms through which polyphenols prevent and 433
destabilize synuclein assemblies. 434
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